COVID-19 vaccine effectiveness monitoring in Australia

被引:1
|
作者
Liu, Bette [1 ]
机构
[1] Sydney Childrens Hosp Network, Natl Ctr Immunisat Res & Surveillance, Kids Res, Locked Bag 4001, Westmead, NSW 2145, Australia
基金
英国医学研究理事会;
关键词
cohort study; COVID-19; mortality; SARS-CoV-2; vaccine effectiveness;
D O I
10.1071/MA24053
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vaccine effectiveness is a measure of vaccine performance in the population usually estimated after the vaccine has been registered and is being used. With continuing evolution of SARS-CoV-2 and new variant-specific vaccines, as well as changes in uptake of vaccination and incidence of infections in the population, continued assessment of COVID-19 vaccine effectiveness is important to inform programmatic and policy decisions. In Australia, COVID-19 vaccine effectiveness against mortality has been assessed regularly using whole of population health data. These analyses have shown how vaccine boosting with the most up to date variant vaccines has been highly effective in reducing COVID-19 deaths in older adults. However, waning of protection continues to be observed supporting the need for regular boosters in older Australian adults and the need to continue to monitor the effectiveness of the COVID-19 vaccine program.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 50 条
  • [21] Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States
    Layton, J. Bradley
    Peetluk, Lauren
    Wong, Hui Lee
    Jiao, Yixin
    Djibo, Djeneba Audrey
    Bui, Christine
    Lloyd, Patricia C.
    Gruber, Joann F.
    Miller, Michael
    Ogilvie, Rachel P.
    Deng, Jie
    Parambi, Ron
    Song, Jennifer
    Weatherby, Lisa B.
    Lo, An-Chi
    Matuska, Kathryn
    Wernecke, Michael
    Clarke, Tainya C.
    Cho, Sylvia
    Bell, Elizabeth J.
    Seeger, John D.
    Yang, Grace Wenya
    Illei, Dora
    Forshee, Richard A.
    Anderson, Steven A.
    McMahill-Walraven, Cheryl N.
    Chillarige, Yoganand
    Amend, Kandace L.
    Anthony, Mary S.
    Shoaibi, Azadeh
    VACCINE: X, 2024, 16
  • [22] Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy
    Vasilev, Georgi
    Kabakchieva, Plamena
    Miteva, Dimitrina
    Batselova, Hristiana
    Velikova, Tsvetelina
    WORLD JOURNAL OF DIABETES, 2022, 13 (09) : 738 - 751
  • [23] Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
    Flacco, Maria Elena
    Soldato, Graziella
    Martellucci, Cecilia Acuti
    Carota, Roberto
    Di Luzio, Rossano
    Caponetti, Antonio
    Manzoli, Lamberto
    VACCINES, 2021, 9 (06)
  • [24] PICK-ing Malaysia's Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio
    Suah, Jing Lian
    Tok, Peter Seah Keng
    Ong, Su Miin
    Husin, Masliyana
    Tng, Boon Hwa
    Sivasampu, Sheamini
    Thevananthan, Thevesh
    Appannan, Maheshwara Rao
    Muhamad Zin, Faizah
    Mohd Zin, Shahanizan
    Yahaya, Hazlina
    Rusli, Norhayati
    Ujang, Mohd Fikri
    Mohd Ibrahim, Hishamshah
    Abdullah, Noor Hisham
    Peariasamy, Kalaiarasu M.
    VACCINES, 2021, 9 (12)
  • [25] A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
    Khandker, Shahad Saif
    Godman, Brian
    Jawad, Md. Irfan
    Meghla, Bushra Ayat
    Tisha, Taslima Akter
    Khondoker, Mohib Ullah
    Haq, Md. Ahsanul
    Charan, Jaykaran
    Talukder, Ali Azam
    Azmuda, Nafisa
    Sharmin, Shahana
    Jamiruddin, Mohd. Raeed
    Haque, Mainul
    Adnan, Nihad
    VACCINES, 2021, 9 (12)
  • [26] Effectiveness of the COVID-19 vaccine in the Honam region of the Republic of Korea
    Shin, In-Sook
    Lee, Yong-Pyo
    Lee, Seung-Hoon
    Lee, Jae-Young
    Park, Jong-Ha
    Chung, Yoon-Seok
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2023, 14 (03) : 197 - 206
  • [27] Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China
    Lu, Jia
    Wen, Xiaosa
    Guo, Qi
    Ji, Mengdi
    Zhang, Felici
    Wagner, Abram L.
    Lu, Yihan
    VACCINES, 2021, 9 (05)
  • [28] Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic
    Lucinde, Ruth Khadembu
    Gathuri, Henry
    Isaaka, Lynda
    Ogero, Morris
    Mumelo, Livingstone
    Kimego, Dennis
    Mbevi, George
    Wanyama, Conrad
    Otieno, Edwin Onyango
    Mwakio, Stella
    Saisi, Metrine
    Isinde, Elizabeth
    Oginga, Irene Njeri
    Wachira, Alvin
    Manuthu, Evans
    Kariuki, Hazel
    Nyikuli, Jared
    Wekesa, Cyprian
    Otedo, Amos
    Bosire, Hannah
    Okoth, Steve Biko
    Ongalo, Winston
    Mukabi, David
    Lusamba, Wilber
    Muthui, Beatrice
    Adembesa, Isaac
    Mithi, Caroline
    Sood, Mohammed
    Ahmed, Nadia
    Gituma, Bernard
    Giabe, Matiko
    Omondi, Charles
    Aman, Rashid
    Amoth, Patrick
    Kasera, Kadondi
    Were, Fred
    Nganga, Wangari
    Berkley, James A.
    Tsofa, Benjamin
    Mwangangi, Jospeh
    Bejon, Philip
    Barasa, Edwine
    English, Mike
    Scott, John Athony Gerard
    Akech, Samuel
    Kagucia, Eunice Wangeci
    Agweyu, Ambrose
    Etyang, Anthony Oliwa
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [29] Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study
    Wang, Tao
    Li, Chaoqun
    Li, Hongyan
    Li, Zheheng
    BMJ OPEN, 2022, 12 (07):
  • [30] COVID-19 Variants and Vaccine Development
    Zhao, Ziyao
    Bashiri, Sahra
    Ziora, Zyta M.
    Toth, Istvan
    Skwarczynski, Mariusz
    VIRUSES-BASEL, 2024, 16 (05):